CN106361909A - Drug for treating recurrent oral ulceration and preparation method thereof - Google Patents
Drug for treating recurrent oral ulceration and preparation method thereof Download PDFInfo
- Publication number
- CN106361909A CN106361909A CN201611062039.1A CN201611062039A CN106361909A CN 106361909 A CN106361909 A CN 106361909A CN 201611062039 A CN201611062039 A CN 201611062039A CN 106361909 A CN106361909 A CN 106361909A
- Authority
- CN
- China
- Prior art keywords
- percent
- radix
- medicine
- recurrent oral
- oral ulceration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating recurrent oral ulceration. The drug comprises effective components and medically acceptable excipients, wherein the effective components are prepared from the following crude drugs by weight percent: 3.5 to 5.5 percent of uroctea compactilis (baked), 3.5 to 5.5 percent of persimmon frost, 3.5 to 5.5 percent of ampelopsis radix, 0.5 to 1.2 percent of pearl powder, 12 to 21 percent of lonicera japonica, 20 to 30 percent of gypsum fibrosum, 10 to 16 percent of gardenia jasminoides, 10 to 16 percent of dark plum fruit, 10 to 16 percent of radix scrophulariae, and 7 to 11 percent of glycyrrhiza uralensis. The drug has the efficacies of antipyresis, detoxication, removing the necrotic tissue and curing ulceration, and has obvious curative effects for curing recurrent oral ulceration.
Description
Technical field:
The present invention relates to medicinal preparation is and in particular to contain the pharmaceutical preparation not determining structure from Uroctea compatilis Koch. section plant.
Background technology:
Recurrent oral ulceration (recurrent oral ulcer, rou) is that repeatedly occur one with oral mucosa or dissipate
In multiple aphthas, it is often accompanied by local redness, burns sample pain, numb, excessive saliva is clinical manifestation.Belong to common oral cavity
Mucous membrane disease, the prevalence of population may be up to 20%, and the sickness rate in oral keritonocytes be in cumulative year after year it
Gesture.This disease has recurrent exerbation, the difficult clinical characters more of delay, and patient feels pain deeply.As with the passing of time do not healed it is possible to develop into
As even more serious disease in malignant tumor etc..The cause of disease of rou and mechanism not yet illustrate so far, and some results of study show may be with
Local wound, pressure, diet, medicine, hormone and vitamin are relevant with factors such as trace element deficiencies.At present for rou's
Treatment there is no specific medicament, although conventional Western medicine is numerous, including external and endo-medicine, also can only reduce the frequency of ulcer generation
Rate and the order of severity mitigating ulcer generation, the general curative effect for oral ulcer is still undesirable.Especially hormone medicine, though
So certain effect can be obtained at short notice, but because its side effect larger it is easy to recurrence and be difficult to popularization and application.
Chinese medicine shows greater advantage in terms of the last disease for the treatment of.A large amount of Chinese medicine study achievements show: recurrent mouth
The main pathological characteristic of chamber ulcer is " burning hot ", and based on excess-fire.Its clinical symptoms is how more with point of bursting, and is notably fused into
Piece, scorching hot pain, and how simultaneous see heating, thirsty, the red, constipation of urinating, red tongue, yellow and greasy fur, rapid pulse.Existing treatment recurrent oral is burst
The Chinese medicine of infectionss is mainly heat clearing and fire purging medicine, such as coptos bolus for clearing the upper heat, and this medicine cures mainly part of the body cavity above the diaphragm housing the heart and lungs interior-heat, symptoms include dizzy, gingival swelling and pain,
Aphtha of the mouth and tongue, pharyngitis, otalgia tinnitus, epidemic hemorrhagic conjunctivitiss, it is hard and dry, yellowish or reddish urine.But coptos bolus for clearing the upper heat clearing away heat-fire
Be only capable of improving the symptom of recurrent oral ulceration, can not removing the necrotic tissue and promoting granulation and effect a permanent cure to reduce relapse rate.
Content of the invention
Problem to be solved by this invention is to provide a kind of medicine treating recurrent oral ulceration, and this medical instrument has solution pyrolysis
The work(of poison, removing the necrotic tissue more infectionss, treatment recurrent oral ulceration is evident in efficacy.
The technical scheme that the present invention solves the above problems is as described below:
A kind of medicine treating recurrent oral ulceration, this medicine is by active ingredient and medically acceptable excipient group
Become, wherein said active ingredient is made up of the crude drug of following percentage by weight:
Uroctea compatilis Koch. (roasting) 3.5~5.5%, Mannosum Kaki 3.5~5.5%, Radix Ampelopsis 3.5~5.5%, Margarita powder 0.5~1.2%, gold
Flos Lonicerae 12~21%, Gypsum Fibrosum 20~30%, Fructus Gardeniae 10~16%, Fructus Mume 10~16%, Radix Scrophulariae 10~16%, Radix Glycyrrhizae 7~12%.
In said medicine, the most preferably proportioning of each crude drug is:
Uroctea compatilis Koch. (roasting) 4%, Mannosum Kaki 4%, Radix Ampelopsis 4%, Margarita powder 0.8%, Flos Lonicerae 16.5%, Gypsum Fibrosum 25%, Fructus Gardeniae
12.5% part, Fructus Mume 12.5%, Radix Scrophulariae 12.5%, Radix Glycyrrhizae 8.2%.
Effective ingredient in said medicine can be obtained using various common preparation methoies, and one of which is simple and easy to do
Method comprises the steps of:
(1) take Uroctea compatilis Koch., dried with slow fire, be ground into fine powder;
(2) take Radix Ampelopsis, be ground into fine powder;
(3) take Mannosum Kaki and Margarita powder, mix with step (1) and (2) gained fine powder;
(4) extracting honeysuckle, adds the water of 10 times amount to soak 1-2 hour, 6~10 hours vapor distillation extraction times, receives
Collection volatile oil, medicinal residues are standby;
(5) Gypsum Fibrosum, Fructus Gardeniae, Fructus Mume, Radix Scrophulariae and Radix Glycyrrhizae and the medicinal residues of step (4) are taken to mix homogeneously, plus 8 each time~10 times
Water, decoct 2 times, collecting decoction, standing 12 hours after, take supernatant and be concentrated into thick paste, add volumetric concentration be 40%~
80% ethanol precipitate with ethanol, stands 24 hours, takes supernatant liquid filtering, decompression recycling ethanol, be then condensed into extractum spray dried
Dry, obtain extract powder;
(6) step (3) and step (5) gained extract powder are mixed homogeneously with step (4) gained volatile oil, obtain final product described
Effective ingredient.
Medicine of the present invention is oral agents, such as granule, capsule or tablet.
The prescription feature of medicine of the present invention: the present invention, according to tcm prescription theory, is tied using monarch compatibility
Structure, makes all medicines work in coordination with compatibility, thus producing overall efficacy, the not simple superposition of drug alone effect, specific as follows:
Uroctea compatilis Koch. salty in the mouth, slight bitter, cool in nature, return lung, liver, large intestine channel, function heat-clearing and toxic substances removing and removing the necrotic tissue;Mannosum Kaki sweet in the mouth, cool in nature, return
The heart, lung, stomach, the heat of kind lung heat clearing stomach;Radix Ampelopsis nature and flavor are bitter, sweet, pungent, cool, enter the heart, liver, spleen channel, function heat-clearing and toxic substances removing, SHENGJISAN
Knot;Margarita nature and flavor are sweet, salty, cold, GUIXIN, Liver Channel, function removing toxic substances and promoting granulation;Four medicine phases 5, have heat-clearing and toxic substances removing, removing the necrotic tissue and promoting granulation function
It is monarch drug altogether.Flos Lonicerae nature and flavor are sweet, tremble with fear, return lung, the heart, stomach, function heat-clearing and toxic substances removing, the heat of cool scattered lung gold;Gypsum Fibrosum nature and flavor are sweet,
Pungent, in Great Cold, attach to the lung and stomach meridians, function clearing away heat-fire, the fire of kind lung heat clearing stomach.Fructus Gardeniae nature and flavor are bitter, tremble with fear, GUIXIN, lung, tri-jiao channel, function
Clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, the fire of clearing away damp-heat from SANJIAO;Three medicine GUIXIN, lung, stomach, tri-jiao channel, help the removing toxic substances of monarch's clearing away heat-fire to be minister altogether
Medicine.Fructus Mume sour in the mouth, puckery, mild-natured, Return liver, spleen, lung, large intestine channel, function YIN nourishing and the production of body fluid promoting;Radix Scrophulariae nature and flavor are sweet, bitter, salty, are slightly cold, and return
Spleen, stomach, kidney channel, function clearing away heat and cooling blood, nourishing YIN to lower pathogenic fire, detoxicating and resolving stagnation of pathogens, two medicines are good at yin nourishing pathogenic fire reducing, primary disease exuberant lung-stomach heat, probably
There is the change of impairment of YIN, thus Kidney-Yin with the big benefit of this two medicine, altogether for adjuvant drug;Radix Glycyrrhizae property is sweet, flat, enter the heart, lung, spleen, stomach, arrogate to oneself most removing toxic substances,
Coordinating the actions of various ingredients in a prescription, therefore for making medicine.Above-mentioned all medicines coordinate, and side plays solution thermal detoxification altogether entirely, the work(of removing the necrotic tissue more infectionss.
The effect of Drug therapy recurrent oral ulceration of the present invention can be obtained into one by the observation of following clinical cases
Step confirms.
Clinical research data
1st, data and standard
1.1st, diagnostic criteria:
A: lung and stomach excessive heat type CM syndrome differentiation criterion: with reference to " new Chinese medicine guideline of clinical investigations " dialectical standard formulation of aphtha.
Primary symptom: ulcer surface differs in size, number is many, and edge is red and swollen, locally scorching hot pain;
Secondary disease: dryness in the nasal cavity, xerostomia or thirsty, implication is smelly dirty, big dry stool, yellow fur, rolling pulse or number;
Possessing primary symptom and more than 3 persons of secondary disease is exuberant lung-stomach heat pattern of syndrome recurrent oral ulceration.
B: recurrent oral ulceration diagnostic criteria: reference " oral mucosal disease " (Chen Qianming. oral mucosal disease the scholar people defend
The raw publishing house third edition in 2010) formulate.
1. oral ulcer, medical history was more than 2 years;
2. the intermission shown effect is 1~3 month;
3. oral ulcer number is less than 3 every time.
1.2nd, case inclusive criteria: meet the dialectical standard of lung and stomach excessive heat type and recurrent oral ulceration diagnostic criteria simultaneously,
Can follow the doctor's advice, and sign Informed Consent Form.
1.3rd, case exclusion standard: do not meet case inclusive criteria;Exclusion behcets disease and oral squamous cell carcinoma patient;Nearly 1
In individual month using antibiotic, glucocorticosteroid hormonal medicaments;It is associated with severe cardiac, brain, lung, kidney or hemopoietic system etc. seriously primary
Property disease patient;Uncooperative or therapy discontinued person.
2nd, case packet
Observe 79 patients altogether, according to medical sequencing row number, odd number is treatment group 40, and even numbers is matched group 39
Example.According to case exclusion standard, observe effective patient 72 altogether, treatment group is 38, matched group 34.
3rd, classified data
Treatment group 38, wherein man 22, female 16,45.3 ± 2.5 years old mean age;Matched group 34, wherein man 19
Example, female 15,44.9 ± 1.8 years old mean age.Through statistics x2Inspection, treatment group and 2 groups of cases of matched group are at sex, age
Aspect there are no significant difference (p > 0.05), has comparability.
4th, research method
4.1st, observation index
1. clinical symptoms and tongue fur, pulse condition;
2. healing;
4.2nd, safety observation: treatment before and after look Liver and kidney function and blood, routine urinalysis, bad thing during observation and treatment
The generation of part.
4.3rd, Therapeutic Method
Treatment group adopts the embodiment of the present invention 1 granule, every time 1 bag, and 2 times a day;Matched group adopts coptos bolus for clearing the upper heat (north
Capital limited company of Tongrentang, authentication code: Chinese medicines quasi-word z11020229), 2 ball every time, 2 times a day, warm boiled water.7
At (1 week) day was 1 course for the treatment of.
4.4th, efficacy assessment standard:
With reference to " recurrent aphtha whole body therapeutic therapeutic evaluation tentative standard ", (Chinese stomatology can oral mucosa
Sick Professional Committee. recurrent aphtha whole body therapeutic therapeutic evaluation tentative standard. modern practicality medical science, 2003,15
(2): 131.) formulate.
Effective: patient's main clinic symptoms disappear, ulcer surface pain disappears, and the ulcerative stage course of disease substantially shortens;
Effective: patient's main clinic symptoms, ulcer surface pain and ulcer situation are relieved;
Invalid: the state of an illness is no alleviated, even having increased.
Calculate total effective rate using effective with effectively with as virtual value.
4.6th, statistical method:
Statistical analysiss are carried out using statistical software spss17.0.Measurement data adopts x2Inspection, enumeration data adopts t to examine
Test, confidence interval is 95%, p < 0.05 is significant difference, has statistical significance.
5th, therapeutic outcome
5.1. 2 groups of Clinical efficacy comparisons
Table 1 treatment group and matched group Clinical efficacy comparison
Note: compare #p < 0.05 with matched group.
Table 1 result shows, two groups of total effectses significant differences, shows Drug therapy lung and stomach excessive heat type recurrent oral of the present invention
The total effectses of ulcer are better than matched group coptos bolus for clearing the upper heat.
5.2nd, safety evaluatio:
Before and after 2 groups of patient's treatments, blood, routine urinalysis and hepatic and renal function inspection have no significant change.Do not find obvious adverse reaction
Event, shows that medicine of the present invention is a safe and effective preparation.
Specific embodiment:
Embodiment 1 (granule):
1st, prescription: Uroctea compatilis Koch. (roasting) 500g, Mannosum Kaki 500g, Radix Ampelopsis 500g, Margarita powder 100g, Flos Lonicerae 2000g, Gypsum Fibrosum
3000g, Fructus Gardeniae 1500g, Fructus Mume 1500g, Radix Scrophulariae 1500g, Radix Glycyrrhizae 1000g.
2 preparation methoies:
1. take Uroctea compatilis Koch., dried with slow fire, be ground into fine powder;
2. take Radix Ampelopsis, be ground into fine powder;
3. Mannosum Kaki, Margarita powder are taken, with step 1. 2. gained fine powder mixing;
4. extracting honeysuckle, adds the water of 10 times amount to soak 1 hour, 8 hours vapor distillation extraction times, collects volatilization
Oil, medicinal residues are standby;
5. 4. remaining medicinal residues are mixed homogeneously to weigh Gypsum Fibrosum, Fructus Gardeniae, Fructus Mume, Radix Scrophulariae, Radix Glycyrrhizae and step according to proportioning, each time
Plus 9 times of decocting boils 2 times, collecting decoction, standing, after about 12 hours, takes supernatant and is concentrated into thick paste, and addition volumetric concentration is
60% ethanol precipitate with ethanol, stands 24 hours, takes supernatant liquid filtering, decompression recycling ethanol, be then condensed into extractum spray dried
Dry, obtain extract powder;
6. by step 3., step 5. gained fine powder 4. gained volatile oil is mixed homogeneously with step, add appropriate dextrin and shallow lake
Powder, then adds water and makes granule, is dried, granulate, and pack is distributed into 10g/ bag.
Embodiment 2 (granule):
1st, prescription: Uroctea compatilis Koch. (roasting) 666g, Mannosum Kaki 605g, Radix Ampelopsis 545g, Margarita powder 82g, Flos Lonicerae 2215g, Gypsum Fibrosum
2723g, Fructus Gardeniae 1573g, Fructus Mume 1210g, Radix Scrophulariae 1392g, Radix Glycyrrhizae 1089g.
2nd, preparation method:
1. take Uroctea compatilis Koch., dried with slow fire, be ground into fine powder;
2. take Radix Ampelopsis, be ground into fine powder;
3. Mannosum Kaki, Margarita powder are taken, with step 1. 2. gained fine powder mixing;
4. extracting honeysuckle, adds the water of 10 times amount to soak 1 hour, 10 hours vapor distillation extraction times, collects volatilization
Oil, medicinal residues are standby;
5. 4. remaining medicinal residues are mixed homogeneously to take Gypsum Fibrosum, Fructus Gardeniae, Fructus Mume, Radix Scrophulariae, Radix Glycyrrhizae and step, each time plus 10 times of water
Decoct 2 times, collecting decoction, standing, after about 12 hours, takes supernatant and is concentrated into thick paste, add the ethanol that volumetric concentration is 80%
Precipitate with ethanol, stands 24 hours, takes supernatant liquid filtering, decompression recycling ethanol, be then condensed into extractum and be spray-dried, obtain extractum
Powder;
6. by step 3., step 5. gained fine powder 4. gained volatile oil is mixed homogeneously with step, add appropriate dextrin and shallow lake
Powder, then adds water and makes granule, is dried, granulate, and pack is distributed into 10g/ bag.
Embodiment 3 (granule):
1st, prescription: Uroctea compatilis Koch. (roasting) 424g, Mannosum Kaki 462g, Radix Ampelopsis 521g, Margarita powder 118g, Flos Lonicerae 2428g, Gypsum Fibrosum
3179g, Fructus Gardeniae 1503g, Fructus Mume 1330g, Radix Scrophulariae 1210g, Radix Glycyrrhizae 925g.
2nd, preparation method:
1. take Uroctea compatilis Koch., dried with slow fire, be ground into fine powder;
2. take Radix Ampelopsis, be ground into fine powder;
3. Mannosum Kaki, Margarita powder are taken, with step 1. 2. gained fine powder mixing;
4. extracting honeysuckle, adds the water of 10 times amount to soak 2 hours, 8 hours vapor distillation extraction times, collects volatilization
Oil, medicinal residues are standby;
5. 4. remaining medicinal residues are mixed homogeneously to take Gypsum Fibrosum, Fructus Gardeniae, Fructus Mume, Radix Scrophulariae, Radix Glycyrrhizae and step, each time plus 8 times of water
Decoct 2 times, collecting decoction, standing, after about 12 hours, takes supernatant and is concentrated into thick paste, add the ethanol that volumetric concentration is 50%
Precipitate with ethanol, stands 24 hours, takes supernatant liquid filtering, decompression recycling ethanol, be then condensed into extractum and be spray-dried, obtain extractum
Powder;
6. by step 3., step 5. gained fine powder 4. gained volatile oil is mixed homogeneously with step, add appropriate dextrin and shallow lake
Powder, then adds water and makes granule, is dried, granulate, and pack is distributed into 10g/ bag.
Embodiment 4 (capsule)
By the drug particles of the method preparation according to embodiment 1, load gelatine capsule, make capsule.
Embodiment 5 (tablet):
Embodiment 1 granule is added water moistening, tabletting, is dried and tablet is obtained.
Claims (4)
1. a kind of medicine treating recurrent oral ulceration, this medicine is by active ingredient and medically acceptable excipient group
Become, wherein said active ingredient is made up of the crude drug of following percentage by weight:
Uroctea compatilis Koch. (roasting) 3.5~5.5%, Mannosum Kaki 3.5~5.5%, Radix Ampelopsis 3.5~5.5%, Margarita powder 0.5~1.2%, Flos Lonicerae
12~21%, Gypsum Fibrosum 20~30%, Fructus Gardeniae 10~16%, Fructus Mume 10~16%, Radix Scrophulariae 10~16%, Radix Glycyrrhizae 7~11%.
2. a kind of medicine treating recurrent oral ulceration according to claim 1 is it is characterised in that described effective one-tenth
Part is made up of the crude drug of following percentage by weight:
Uroctea compatilis Koch. (roasting) 4%, Mannosum Kaki 4%, Radix Ampelopsis 4%, Margarita powder 0.8%, Flos Lonicerae 16.5%, Gypsum Fibrosum 25%, Fructus Gardeniae 12.5%
Part, Fructus Mume 12.5%, Radix Scrophulariae 12.5%, Radix Glycyrrhizae 8.2%.
3. a kind of medicine treating recurrent oral ulceration according to claim 1 and 2 is it is characterised in that described has
Effect composition is obtained by following methods:
(1) take Uroctea compatilis Koch., dried with slow fire, be ground into fine powder;
(2) take Radix Ampelopsis, be ground into fine powder;
(3) take Mannosum Kaki and Margarita powder, mix with step (1) and (2) gained fine powder;
(4) extracting honeysuckle, adds the water of 10 times amount to soak 1-2 hour, 6~10 hours vapor distillation extraction times, collection is waved
Hair oil, medicinal residues are standby;
(5) Gypsum Fibrosum, Fructus Gardeniae, Fructus Mume, Radix Scrophulariae and Radix Glycyrrhizae and the medicinal residues of step (4) are taken to mix homogeneously, plus 8 each time~10 times
Water, decoct 2 times, collecting decoction, standing 12 hours after, take supernatant and be concentrated into thick paste, add volumetric concentration be 40%~
80% ethanol precipitate with ethanol, stands 24 hours, takes supernatant liquid filtering, decompression recycling ethanol, be then condensed into extractum spray dried
Dry, obtain extract powder;
(6) step (3), step (5) gained extract powder are mixed homogeneously with step (4) gained volatile oil, obtain final product described effective
Composition.
4. a kind of medicine treating recurrent oral ulceration according to claim 3 is it is characterised in that described medicine is
Granule, capsule or tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611062039.1A CN106361909A (en) | 2016-11-28 | 2016-11-28 | Drug for treating recurrent oral ulceration and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611062039.1A CN106361909A (en) | 2016-11-28 | 2016-11-28 | Drug for treating recurrent oral ulceration and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106361909A true CN106361909A (en) | 2017-02-01 |
Family
ID=57891597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611062039.1A Pending CN106361909A (en) | 2016-11-28 | 2016-11-28 | Drug for treating recurrent oral ulceration and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106361909A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108904539A (en) * | 2018-07-23 | 2018-11-30 | 广东永青生物科技有限公司 | Application of the pearl fructose composite in preparation prevention and treatment mouth ulcer lozenge |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101204527A (en) * | 2007-11-29 | 2008-06-25 | 北京中科雍和医药技术有限公司 | Medicaments composite for recurrent oral ulcer and preparation method thereof |
-
2016
- 2016-11-28 CN CN201611062039.1A patent/CN106361909A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101204527A (en) * | 2007-11-29 | 2008-06-25 | 北京中科雍和医药技术有限公司 | Medicaments composite for recurrent oral ulcer and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108904539A (en) * | 2018-07-23 | 2018-11-30 | 广东永青生物科技有限公司 | Application of the pearl fructose composite in preparation prevention and treatment mouth ulcer lozenge |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698097B (en) | Traditional Chinese medicinal composition for treating paradentitis, and formulation and preparation method thereof and toothpaste | |
CN102133271B (en) | Medicinal tea for curing gout | |
CN104491695A (en) | Pharmaceutical composition for treating chloasma | |
CN100548324C (en) | A kind of external medicine preparation for the treatment of disease caused by acarids | |
CN103656403A (en) | Traditional Chinese medicine composition for treating phthisis and preparation method of traditional Chinese medicine composition | |
CN102302758B (en) | Pharmaceutical composition for treating functional dyspepsia (FD) based on intermingled cold and heat symptom and preparation method thereof | |
CN110812417A (en) | Composition for treating constipation, preparation and application | |
CN104225450A (en) | Traditional Chinese medicine for treating depression | |
CN106138668A (en) | A kind of Chinese medicine composition treating COPD and preparation method thereof | |
CN102552520B (en) | Blood circulation-promoting and pain-stopping medicament and preparation process and application thereof | |
CN102716334A (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
CN106361909A (en) | Drug for treating recurrent oral ulceration and preparation method thereof | |
CN104548029A (en) | Pharmaceutical composition for treating epigastric pain | |
CN104436048A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating qi stagnation and blood stasis type chloasma | |
CN101745048B (en) | Medicine for treating type II diabetes and resisting aging | |
CN114224998A (en) | Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type functional dyspepsia, preparation and application | |
CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
CN104800675A (en) | Medicament for treating active ulcerative colitis | |
CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
CN102813875B (en) | Traditional Chinese medicine composition for treating lupus erythematosus as well as application thereof | |
CN104324134A (en) | Traditional Chinese medicine composition for improving microcirculation and preparation method of traditional Chinese medicine composition | |
CN104043008A (en) | External traditional Chinese medicinal composition for treating myofascitis and preparation method thereof | |
CN102727766A (en) | Traditional Chinese medicinal preparation for treating comprehensive hemorrhoids, and preparation method thereof | |
CN102631618A (en) | Traditional Chinese medicine for treating diabetes | |
CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |
|
RJ01 | Rejection of invention patent application after publication |